Correspondence 0001104659-23-004856 from Carisma Therapeutics Inc. (CARM) (CIK 0001485003) (CARM)

Carisma Therapeutics Inc. (CARM) (CIK 0001485003)
Date: Jan. 19, 2023 · CIK: 0001485003 · Accession: 0001104659-23-004856

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-267891

Date

January 19, 2023

Author

Not clearly detected

Form

CORRESP

Company

Carisma Therapeutics Inc. (CARM) (CIK 0001485003)

Letter

Office of Life Sciences Division of Corporation Finance Attention: Ada D. Sarmento & Dillon Hagius Re: Sesen Bio, Inc. Registration Statement on Form S-4 (File No. 333-267891) Request for Acceleration of Effective Date

Dear Ms. Sarmento & Mr. Hagius:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Sesen Bio, Inc. (the “Company”) hereby respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date and time of the above referenced Registration Statement on Form S-4 (the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern Time on January 19, 2023, or as soon thereafter as practicable.

The Company requests that it be notified of such effectiveness by a telephone call to Tiffany Posil of Hogan Lovells US LLP at (202) 637-3663.

[Signature page follows]

Sincerely,
Sesen Bio, Inc.

Show Raw Text

CORRESP
1
filename1.htm

January 19, 2023

CORRESPONDENCE FILED VIA EDGAR

Office of Life Sciences

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Ada D. Sarmento & Dillon Hagius

  Re:
  Sesen Bio, Inc.

Registration Statement on Form S-4 (File No.
333-267891)

Request for Acceleration of Effective Date

Dear Ms. Sarmento & Mr. Hagius:

Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended, Sesen Bio, Inc. (the “Company”) hereby
respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date and time of the above referenced
Registration Statement on Form S-4 (the “Registration Statement”) and declare the Registration Statement effective
as of 4:00 p.m. Eastern Time on January 19, 2023, or as soon thereafter as practicable.

The Company requests that
it be notified of such effectiveness by a telephone call to Tiffany Posil of Hogan Lovells US LLP at (202) 637-3663.

[Signature page follows]

    Sincerely,

     Sesen Bio, Inc.

    /s/ Mark R. Sullivan

    Mark R. Sullivan

    General Counsel, Chief Compliance Officer and Corporate Secretary

SecProbe.io